Skip To Main Content

Venetoclax (BCL-2 inhibitor)

(RG7601, ABT-199)

Hematology

Phase II

Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (MM)

NCT02899052